![Nicolas Sitchon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicolas Sitchon
Algemeen Directeur bij S1 BioPharma, Inc.
Profiel
Nicolas Gomez Sitchon is currently the Chairman, President & Chief Executive Officer at S1 BioPharma, Inc. He has been in this position since 2010.
He has a graduate degree from Boston University School of Medicine and an MBA from Questrom School of Business.
Actieve functies van Nicolas Sitchon
Bedrijven | Functie | Begin |
---|---|---|
S1 BioPharma, Inc.
![]() S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Algemeen Directeur | 01-10-2010 |
Opleiding van Nicolas Sitchon
Boston University School of Medicine | Graduate Degree |
Questrom School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
S1 BioPharma, Inc.
![]() S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Health Technology |